Kansas City Oncology and Hematology Group — Overland Park, Kansas

Kansas City Oncology and Hematology Group is a clinical research site located in Overland Park, Kansas, United States 66210.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Kansas City Oncology and Hematology Group has participated in 2 clinical trials.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Breast Cancer, Adenocarcinoma.

Sponsors: Sanofi, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kansas City Oncology and Hematology Group?

Kansas City Oncology and Hematology Group has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kansas City Oncology and Hematology Group conducted?

Kansas City Oncology and Hematology Group has 2 clinical trials on record. Their work covers Carcinoma, Non-Small-Cell Lung, Breast Cancer, Adenocarcinoma.

Is Kansas City Oncology and Hematology Group accredited by Crixeo Health?

Kansas City Oncology and Hematology Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kansas City Oncology and Hematology Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.